Intervention Review

Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients

  1. Katherine Ngo1,*,
  2. Dipak Kotecha2,
  3. Julia AE Walters3,
  4. Luis Manzano4,
  5. Alberto Palazzuoli5,
  6. Dirk J van Veldhuisen6,
  7. Marcus Flather2

Editorial Group: Cochrane Heart Group

Published Online: 20 JAN 2010

Assessed as up-to-date: 5 MAR 2009

DOI: 10.1002/14651858.CD007613.pub2

How to Cite

Ngo K, Kotecha D, Walters JAE, Manzano L, Palazzuoli A, van Veldhuisen DJ, Flather M. Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD007613. DOI: 10.1002/14651858.CD007613.pub2.

Author Information

  1. 1

    University of Tasmania, School of Medicine, Hobart, Tasmania, Australia

  2. 2

    National Heart and Lung Institute, Imperial College, Clinical Trials & Evaluation Unit, Royal Brompton Hospital, London, UK

  3. 3

    University of Tasmania, Menzies Research Institute, Hobart, Tasmania, Australia

  4. 4

    Universidad de Alcala, Hospital Universitario Ramon y Cajal, Department of Medicine, Service of Internal Medicine, Madrid, Madrid, Spain

  5. 5

    University of Siena, Le Scotte Hospital, Internal Medicine and Metabolic Diseases, Siena, Siena, Italy

  6. 6

    University Medical Centre Groningen, Cardiology, Groningen, Netherlands

*Katherine Ngo, School of Medicine, University of Tasmania, 43 Collins Street, Hobart, Tasmania, 7005, Australia.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 20 JAN 2010


Cited in:


This article has been cited by:

  1. 1
    Simon Reinke, William R. Taylor, Georg N. Duda, Stephan von Haehling, Petra Reinke, Hans-Dieter Volk, Stefan D. Anker, Wolfram Doehner, Absolute and functional iron deficiency in professional athletes during training and recovery, International Journal of Cardiology, 2012, 156, 2, 186


  2. 2
    Sarah L. Davis, T.J. Littlewood, The investigation and treatment of secondary anaemia, Blood Reviews, 2012, 26, 2, 65


  3. 3
    Claudio Ronco, Edgar V. Lerma, Nephrology Secrets, 2012,


  4. You have free access to this content4
    Bassel Noumi, Sergio Teruya, Say Salomon, Stephen Helmke, Mathew S. Maurer, Blood Volume Measurements in Patients With Heart Failure and a Preserved Ejection Fraction: Implications for Diagnosing Anemia, Congestive Heart Failure, 2011, 17, 1
  5. 5
    Patrick R. Lawler, Kristian B. Filion, Mark J. Eisenberg, Correcting Anemia in Heart Failure: The Efficacy and Safety of Erythropoiesis-Stimulating Agents, Journal of Cardiac Failure, 2010, 16, 8, 649


  6. 6
    Andrés M Acevedo, Myriam Lucía Rodríguez, Henry A Becerra, Andrés Felipe Cardona, Arturo J Martí-Carvajal, Erythropoiesis-stimulating agents for myelodysplastic syndromes, The Cochrane Library,
  7. 7
    Cathy Payne, Philip J Wiffen, Suzanne Martin, Interventions for fatigue and weight loss in adults with advanced progressive illness, The Cochrane Library,
  8. 8
    Bita Mesgarpour, Benedikt H Heidinger, Dominik Roth, Susanne Schmitz, Cathal D Walsh, Harald Herkner, Safety of off-label erythropoiesis-stimulating agents for critically ill patients, The Cochrane Library,